Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Jirina Bartůnková"'
Autor:
Jiřina Bartůňková
Publikováno v:
Onco, Vol 4, Iss 1, Pp 46-55 (2024)
Epithelial ovarian carcinoma (EOC) is the fifth leading cause of cancer-related death in women, largely reflecting the early dissemination of this malignant disease to the peritoneum. Due to its immunological features, EOC has poor response to immune
Externí odkaz:
https://doaj.org/article/9ba1903b4a5a4c91a9fc3f68be3d8185
Autor:
Lenka Rajsiglova, Michal Babic, Katerina Krausova, Pavol Lukac, Katerina Kalkusova, Pavla Taborska, Ludek Sojka, Jirina Bartunkova, Dmitry Stakheev, Luca Vannucci, Daniel Smrz
Publikováno v:
Journal of Immunotoxicology, Vol 21, Iss 1 (2024)
Nanoparticles are commonly used in diagnostics and therapy. They are also increasingly being implemented in cancer immunotherapy because of their ability to deliver drugs and modulate the immune system. However, the effect of nanoparticles on immune
Externí odkaz:
https://doaj.org/article/faad2b3f2a964152a6f8f1f3a094e31d
Autor:
Martina Borcinova, Robin Bartolini, Lily Koumbas Foley, Vojtech Novak, Pavla Taborska, Dmitry Stakheev, Michal Rataj, Daniel Smrz, Martina Fialova, Jaromir Hacek, Martin Komarc, Stepan Vesely, Marek Babjuk, Ilja Striz, Jirina Bartunkova, Tomas Buchler, Zuzana Ozaniak Strizova
Publikováno v:
Translational Oncology, Vol 42, Iss , Pp 101891- (2024)
Renal cell carcinoma (RCC) is a common malignancy frequently diagnosed at the metastatic stage. We performed a comprehensive analysis of the tumor immune microenvironment (TIME) in RCC patients, including the peritumoral tissue microenvironment, to c
Externí odkaz:
https://doaj.org/article/b45ce9ed86cf4aa798f89ac36853a827
Autor:
Katerina Kalkusova, Pavla Taborska, Dmitry Stakheev, Michal Rataj, Sindija Smite, Elea Darras, Julia Albo, Jirina Bartunkova, Luca Vannucci, Daniel Smrz
Publikováno v:
Journal of Immunology Research, Vol 2024 (2024)
CD8+ T cells are essential for adaptive immunity against infection and tumors. Their ability to proliferate after stimulation is crucial to their functionality. Dendritic cells (DCs) are professional antigen-presenting cells that induce their prolife
Externí odkaz:
https://doaj.org/article/a9d4d49b96214e35a2c7f08f4309ad5f
Autor:
Michal Votava, Robin Bartolini, Linda Capkova, Jitka Smetanova, Vachtenheim Jiri, Martin Kuchar, David Kalfert, Jan Plzak, Jirina Bartunkova, Zuzana Strizova
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Salivary gland carcinomas (SGC) are extremely rare malignancies with only limited treatment options for the metastatic phase of the disease. Treatment with anti-CD47 antibodies could represent a potent therapy for SGCs by promotin
Externí odkaz:
https://doaj.org/article/c09c163848b14ef1a436908b017a3737
Autor:
Pavla Taborska, Jan Lastovicka, Dmitry Stakheev, Zuzana Strizova, Jirina Bartunkova, Daniel Smrz
Publikováno v:
Immunity, Inflammation and Disease, Vol 9, Iss 4, Pp 1452-1467 (2021)
Abstract Introduction The COVID‐19 vaccine was designed to provide protection against infection by the severe respiratory coronavirus 2 (SARS‐CoV‐2) and coronavirus disease 2019 (COVID‐19). However, the vaccine's efficacy can be compromised i
Externí odkaz:
https://doaj.org/article/c76674d72c464dc19ea0dc2ddfead6dd
Autor:
Michal Hensler, Jana Rakova, Lenka Kasikova, Tereza Lanickova, Josef Pasulka, Peter Holicek, Marek Hraska, Tereza Hrnciarova, Pavla Kadlecova, Andreu Schoenenberger, Klara Sochorova, Daniela Rozkova, Ludek Sojka, Jana Drozenova, Jan Laco, Rudolf Horvath, Michal Podrazil, Guo Hongyan, Tomas Brtnicky, Michal J. Halaska, Lukas Rob, Ales Ryska, An Coosemans, Ignace Vergote, Abhishek D. Garg, David Cibula, Jirina Bartunkova, Radek Spisek, Jitka Fucikova
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
Dendritic cells (DCs) have received considerable attention as potential targets for the development of novel cancer immunotherapies. However, the clinical efficacy of DC-based vaccines remains suboptimal, largely reflecting local and systemic immunos
Externí odkaz:
https://doaj.org/article/8aa6cc35d16f49fbb0529e5fcefe2e0f
Autor:
Michal Podrazil, Pavla Taborska, Dmitry Stakheev, Michal Rataj, Jan Lastovicka, Alena Vlachova, Petr Pohunek, Jirina Bartunkova, Daniel Smrz
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Coronavirus disease 2019 (COVID-19) vaccines effectively elicit humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in healthy populations. This immunity decreases several months after vaccination. Howev
Externí odkaz:
https://doaj.org/article/9482409c611d4c20a19528c347a23d37
Autor:
David Cibula, Pawel Knapp, Bohuslav Melichar, Jiřina Bartůňková, Radek Špíšek, Lukas Rob, Jitka Fucikova, Peter Mallmann, Lubos Minar, Marek Pluta, Jaroslav Klát, Jirí Špacek, Pavel Bartos, Josef Chovanec, Petr Valha, Zdenek Novotny, Dariusz Kieszko, Tereza Hrnciarova, Roman Pawel Korolkiewicz, Marek Hraska
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/54582ca5443540829196267e9ec3d8e8
Publikováno v:
Pathogens, Vol 12, Iss 1, p 109 (2023)
In 2019, the novel coronavirus, SARS-CoV-2, caused a worldwide pandemic, affecting more than 630 million individuals and causing 6.5 million deaths. In the general population, poorer outcomes have been associated with older age, chronic lung and card
Externí odkaz:
https://doaj.org/article/e235d057225545488fb411c64cce1700